ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,756Medicare Part D Prescriptions Filled, Including Refills

Rank: 142 out of 783

$1.35M Total Retail Price of All Prescriptions

Rank: 16 out of 783

475 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 475 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,197 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$115 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 474 461 1 1
OMEPRAZOLE 355 279 2 6
HYDROCODONE-ACETAMINOPHEN 351 261 S3 3 2
PRAVASTATIN SODIUM 310 242 4 14
CRESTOR 261 257 5 27
AMLODIPINE BESYLATE 255 226 6 5
CLOPIDOGREL 238 230 7 29
DIOVAN 233 233 8 49
LEVOFLOXACIN 176 137 9 75
METFORMIN HCL 176 153 9 8
PLAVIX 170 170 11 51
FUROSEMIDE 163 141 12 7
GABAPENTIN 157 115 13 15
NAMENDA 147 147 14 32
WARFARIN SODIUM 137 137 15 10
CEFDINIR 136 121 16 210
NAPROXEN 126 106 17 104
DIOVAN HCT 124 124 18 94
AZITHROMYCIN 118 95 19 41
CARVEDILOL 116 114 20 21
FENOFIBRATE 116 95 20 66
TRAMADOL HCL 113 90 22 20
ALLOPURINOL 110 101 23 31
RAMIPRIL 110 108 23 113
ATORVASTATIN CALCIUM 109 98 25 11
TAMSULOSIN HCL 108 108 26 26
SUCRALFATE 107 77 27 190
METOPROLOL SUCCINATE 106 96 28 13
BENICAR 99 95 29 182
SIMVASTATIN 97 92 30 3
SINGULAIR 96 84 31 90
SYNTHROID 96 86 31 47
ROPINIROLE HCL 91 67 33 74
NEXIUM 86 48 34 28
PREDNISONE 85 75 35 36
NATEGLINIDE 82 79 36 274
BYSTOLIC 79 68 37 99
KLOR-CON M20 78 73 38 48
LOSARTAN POTASSIUM 78 62 38 18
ZOLPIDEM TARTRATE 78 60 38 23
WELCHOL 77 69 41 234
LISINOPRIL 75 67 42 4
POTASSIUM CHLORIDE 74 67 43 16
PANTOPRAZOLE SODIUM 74 72 43 30
LANSOPRAZOLE 74 74 43 177
GLIMEPIRIDE 73 65 46 34
ZETIA 70 65 47 80
ADVAIR DISKUS 69 38 48 50
DEXILANT 68 62 49 225
LOVAZA 68 58 49 163
CYMBALTA 66 49 51 35
CIPROFLOXACIN HCL 66 62 51 62
METOPROLOL TARTRATE 60 43 53 9
BENICAR HCT 58 58 54 201
CITALOPRAM HBR 58 46 54 19
SPIRIVA 57 40 56 59
TRIAMCINOLONE ACETONIDE 57 40 56 151
ONGLYZA 56 56 58 240
EXFORGE 56 48 58 223
AVODART 55 55 60 263
SPIRONOLACTONE 53 43 61 57
FINASTERIDE 51 51 62 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.